Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Merck
Harvard Business School
Mallinckrodt
Johnson and Johnson

Last Updated: January 29, 2020

DrugPatentWatch Database Preview

Formulation information for generic ingredient: ELTROMBOPAG OLAMINE

See Plans and Pricing

« Back to Dashboard

Eltrombopag

CASRN: 496775-61-2

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Express Scripts
Baxter
Merck
Johnson and Johnson